These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28903033)

  • 1. Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824.
    Cellitti SE; Shaffer J; Jones DH; Mukherjee T; Gurumurthy M; Bursulaya B; Boshoff HI; Choi I; Nayyar A; Lee YS; Cherian J; Niyomrattanakit P; Dick T; Manjunatha UH; Barry CE; Spraggon G; Geierstanger BH
    Structure; 2013 Jan; 21(1):191. PubMed ID: 28903033
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824.
    Cellitti SE; Shaffer J; Jones DH; Mukherjee T; Gurumurthy M; Bursulaya B; Boshoff HI; Choi I; Nayyar A; Lee YS; Cherian J; Niyomrattanakit P; Dick T; Manjunatha UH; Barry CE; Spraggon G; Geierstanger BH
    Structure; 2012 Jan; 20(1):101-12. PubMed ID: 22244759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles.
    Gurumurthy M; Mukherjee T; Dowd CS; Singh R; Niyomrattanakit P; Tay JA; Nayyar A; Lee YS; Cherian J; Boshoff HI; Dick T; Barry CE; Manjunatha UH
    FEBS J; 2012 Jan; 279(1):113-25. PubMed ID: 22023140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro Susceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn, the Deazoflavin-Dependent Nitroreductase from
    Zhang F; Li S; Wen S; Zhang T; Shang Y; Huo F; Xue Y; Li L; Pang Y
    Infect Drug Resist; 2020; 13():815-822. PubMed ID: 32210596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of 2-Nitroimidazooxazine Derivatives as Deazaflavin-Dependent Nitroreductase (Ddn) Activators as Anti-Mycobacterial Agents Based on 3D QSAR, HQSAR, and Docking Study with In Silico Prediction of Activity and Toxicity.
    Gupta N; Vyas VK; Patel BD; Ghate M
    Interdiscip Sci; 2019 Jun; 11(2):191-205. PubMed ID: 28895050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protonation state of F420H2 in the prodrug-activating deazaflavin dependent nitroreductase (Ddn) from Mycobacterium tuberculosis.
    Mohamed AE; Ahmed FH; Arulmozhiraja S; Lin CY; Taylor MC; Krausz ER; Jackson CJ; Coote ML
    Mol Biosyst; 2016 Apr; 12(4):1110-3. PubMed ID: 26876228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies.
    Denny WA; Palmer BD
    Future Med Chem; 2010 Aug; 2(8):1295-304. PubMed ID: 21426020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophobic Shielding Drives Catalysis of Hydride Transfer in a Family of F
    Mohamed AE; Condic-Jurkic K; Ahmed FH; Yuan P; O'Mara ML; Jackson CJ; Coote ML
    Biochemistry; 2016 Dec; 55(49):6908-6918. PubMed ID: 27951661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis.
    Haver HL; Chua A; Ghode P; Lakshminarayana SB; Singhal A; Mathema B; Wintjens R; Bifani P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5316-23. PubMed ID: 26100695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053.
    Chiarelli LR; Salina EG; Mori G; Azhikina T; Riabova O; Lepioshkin A; Grigorov A; Forbak M; Madacki J; Orena BS; Manfredi M; Gosetti F; Buzzi A; Degiacomi G; Sammartino JC; Marengo E; Korduláková J; Riccardi G; Mikušová K; Makarov V; Pasca MR
    ACS Infect Dis; 2020 Feb; 6(2):313-323. PubMed ID: 31729215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adduct Formation of Delamanid with NAD in Mycobacteria.
    Hayashi M; Nishiyama A; Kitamoto R; Tateishi Y; Osada-Oka M; Nishiuchi Y; Kaboso SA; Chen X; Fujiwara M; Inoue Y; Kawano Y; Kawasaki M; Abe T; Sato T; Kaneko K; Itoh K; Matsumoto S; Matsumoto M
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretomanid for the treatment of pulmonary tuberculosis.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2020 Oct; 56(10):655-668. PubMed ID: 33185630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis.
    Negri A; Javidnia P; Mu R; Zhang X; Vendome J; Gold B; Roberts J; Barman D; Ioerger T; Sacchettini JC; Jiang X; Burns-Huang K; Warrier T; Ling Y; Warren JD; Oren DA; Beuming T; Wang H; Wu J; Li H; Rhee KY; Nathan CF; Liu G; Somersan-Karakaya S
    ACS Infect Dis; 2018 May; 4(5):771-787. PubMed ID: 29465985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
    Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M
    Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a Dehalogenase into a Nitroreductase by Swapping its Flavin Cofactor with a 5-Deazaflavin Analogue.
    Su Q; Boucher PA; Rokita SE
    Angew Chem Int Ed Engl; 2017 Aug; 56(36):10862-10866. PubMed ID: 28666054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of an F
    Nguyen QT; Trinco G; Binda C; Mattevi A; Fraaije MW
    Appl Microbiol Biotechnol; 2017 Apr; 101(7):2831-2842. PubMed ID: 27966048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F420H2 Is Required for Phthiocerol Dimycocerosate Synthesis in Mycobacteria.
    Purwantini E; Daniels L; Mukhopadhyay B
    J Bacteriol; 2016 Aug; 198(15):2020-8. PubMed ID: 27185825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium leprae is naturally resistant to PA-824.
    Manjunatha UH; Lahiri R; Randhawa B; Dowd CS; Krahenbuhl JL; Barry CE
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3350-4. PubMed ID: 17005816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.